|
Orenes-Piñero E, Hernández-Romero D, Jover E, Valdés M, Lip GY, Marín F. Impact of polymorphisms in the renin-angiotensin-aldosterone system on hypertrophic cardiomyopathy. J Renin Angiotensin Aldosterone Syst. 2011 Dec;12(4):521-30. doi: 10.1177/1470320311405247. Epub 2011 Apr 20. Review. PubMed PMID: 21507890.
AÑO: 2011; IF: 2.439
|
21507890
|
Orenes-Piñero E, Hernández-Romero D, Jover E, de la Morena G, Valdés M, Marín F. An insight of novel pharmacological therapies in hypertrophic cardiomyopathy. Med Chem. 2011 Jul;7(4):275-85. Review. PubMed PMID: 21568880.
AÑO: 2011; IF: 1.496
|
|
Muñoz-Esparza C, Jover E, Hernández-Romero D, Saura D, Valdés M, Lip GY, Marín F. Interactions between clopidogrel and proton pump inhibitors: a review of evidence. Curr Med Chem. 2011;18(16):2386-400. Review. PubMed PMID: 21568918.
AÑO: 2011; IF: 4.859
|
|
Vílchez JA, Hernández-Romero D, Ruiz-Espejo F, Garcia-Honrubia A, Valdés M, Martínez-Hernández P, Marín F. Collagen peptides, interstitial remodelling and sudden cardiac death in hypertrophic cardiomyopathy. Clin Chem Lab Med. 2011 Sep;49(9):1569-71. doi: 10.1515/CCLM.2011.642. Epub 2011 Jun 13. PubMed PMID: 21663563.
AÑO: 2011; IF: 2.15
|
|
Montoro-García S, Shantsila E, Marín F, Blann A, Lip GY. Circulating microparticles: new insights into the biochemical basis of microparticle release and activity. Basic Res Cardiol. 2011 Nov;106(6):911-23. doi: 10.1007/s00395-011-0198-4. Epub 2011 Jun 21. PubMed PMID: 21691898.
AÑO: 2011; IF: 7.348
|